Skip to main content

News

By Adam Ang | 03:43 am | March 22, 2023
It now plans to release more hypnosis-based DTx apps for anxiety, sleep, and chronic pain.
By Emily Olsen | 03:24 pm | March 21, 2023
Maven said the acquisition of Naytal will accelerate its growth in the U.K. and Europe.
By Emily Olsen | 12:35 pm | March 21, 2023
Nuance Communications said the app creates notes based on patient conversations that clinicians can then review.
By Jessica Hagen | 11:32 am | March 21, 2023
The company will use the funds to circulate its ArteraAI Prostate Test and to develop tests to support individualized therapy options for other cancers.
By Adam Ang | 03:56 am | March 21, 2023
The antiviral medication was found to interact with over 2,000 prescription drugs.
By Jessica Hagen | 03:25 pm | March 20, 2023
The collaboration will expand MedArrive's maternal care services for managed Medicaid health plan members.
By Jessica Hagen | 11:05 am | March 20, 2023
Ida Tin, cofounder and chairwoman at Clue, explains how she sees the fall of Silicon Valley Bank affecting femtech investments and how the sector could progress fruitfully.
By Adam Ang | 08:18 am | March 20, 2023
AI will be integrated to increase pathologists' efficiency.
By Adam Ang | 03:23 am | March 20, 2023
There could be drug misuse and adverse side effects and drug interactions with mobile app prescribing.
By Adam Ang | 03:17 am | March 20, 2023
VC funding in the world's second-biggest digital health ecosystem decreased by 41% year-on-year.